Key Statistics
Market Cap$147.25M
P/E Ratio8.7
Div. Yield—
EPS (TTM)$0.07
52W High$0.84
52W Low$0.26
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees—
Price Performance
1 Week-6.15%
3 Month+60.02%
1 Year+60.86%
FinancialsAnnual · QuiverQuant
Revenue$7.38M
Assets$91.83M
Liabilities$34.02M
Net Income$82.47M loss
About
Vaxart, Inc., a clinical-stage biotechnology company, is dedicated to the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company is headquartered in South San Francisco, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze VXRT with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.